The Quest has been an attempt of IHF to scout and support innovations for infectious diseases since 2017.
Innovations in the infectious diseases segment have historically suffered from de-prioritization in terms of investments. The diseases contributing heavily to the global burden of healthcare have been known to severely affect the LMIC population. With the advent and impact of COVID 2019, this has changed. The world has woken up to the need and urgency towards innovation for the eradication of infectious diseases.
The purpose is to find novel solutions to some of the most pressing problems affecting the control, care, and cure of infectious diseases. Quest 2022 will aim to find solutions in three focus areas.
- Screening and Diagnosis tools for airborne/vector-borne infections and/or febrile illnesses
- Care Pathways
- Disease Surveillance
The need gaps are defined in consultation with eminent experts, practitioners, and partners of repute from government, civil society organizations, academia, and the industry. Through this Quest, we aim to invite science and technology-backed, platform-based multi-disease/modular innovations, which have the potential to scale and percolate to primary healthcare levels.
Detailed problem statements with descriptions under the three focus areas are written in the next section. Applicants are required to adapt their innovation and interest according to all economic and social settings of high relevance relating to quality, epidemiology, field performance, feasibility, acceptability, impact, cost-effectiveness, and sustainability. Endpoints will be compared to baseline measures wherever relevant.
All proposals need to align with at least one of the above focus areas. If applicants are applying for multiple solutions in one or more than one focus areas, then they will be required to submit separate applications for each innovation.
A Joint Initiative By
India Health Fund
India Health Fund (IHF), incorporated as Confluence for Health Action and Transformation Foundation (under Section 8 of Companies Act, 2013), was seeded in 2017 by Tata Trusts and with strategic support from The Global Fund to fight AIDS, Tuberculosis, and Malaria. IHF was conceived to help accelerate progress towards the elimination of infectious diseases. We do this by addressing the gaps in funding for product development, mentorship, and market scale-up, often faced by small and mid-size entities, with powerful ideas that have the potential to make a significant difference in achieving better healthcare outcomes. IHF supports the development of effective business models, enables collaborations, and develops financing mechanisms, all with the objective of ensuring a wide scale-up of solutions that can deliver extensive and significant outcomes in healthcare.
Bhubaneswar City Knowledge Innovation Cluster Foundation (BCKICF), incorporated under Section 8 of Companies Act, 2013 in the state of Odisha is one of the S&T Clusters under the aegis of Office of the Principal Scientific Advisor to the Government of India to facilitate creation of an Atmanirbhar Bharat through Science & Technology. BCKICF strives to create strong linkages between academic institutions, national & state research laboratories, and other key stakeholders like relevant ministries, industry partners, start-ups, MSMEs, state governments, philanthropic foundations, and international organizations for the convergence of initiatives and translational benefits of researches undertaken. Objective is to facilitate seamless multi-institution research and deployment for the solution of major problems faced regionally, nationally and globally.
KIIT-Technology Business Incubator
Started in 2009 as an initiative of the Kalinga Institute of Industrial Technology with the humble support of the Department of Science & Technology (DST), Govt. of India, KIIT – Technology Business Incubator has always strived to boost the entrepreneurial ecosystem in the country. Comprising of a passionate young team and inspiring leadership, today KIIT-TBI stands strong and delivers what is in the best interest of Patients with Infectious diseases. They are the epicentre for technology startups and entrepreneurs in the east and northeast region. KIIT-TBI is also a recipient of the National Award for TBI of the year 2017 by the Department of Science & Technology, Govt of India & in 2020, Granted Centre of Excellence in Incubation & Entrepreneurship from DST, GoI. KIIT-TBI has also been ranked No. 1 Bioincubator consecutively in 2019 and 2020 in the private sector by BioSpectrum